HORMONE-REFRACTORY PROSTATE CANCER-NEW OPTIONS FOR ITS MANAGEMENT

被引:0
|
作者
Holubec, L.
Klecka, J.
Topolcan, O.
Pesta, M.
Eret, V.
Finek, J.
Hora, M.
机构
[1] Fac Hosp, Plzen 30599, Czech Republic
[2] Med Sch Pilsen, Plzen 30599, Czech Republic
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
277
引用
收藏
页码:3319 / 3319
页数:1
相关论文
共 50 条
  • [1] Treatment options for hormone-refractory prostate cancer
    Heidenreich, A
    Ohlmann, CH
    [J]. UROLOGE, 2005, 44 (11): : 1303 - +
  • [2] Therapeutic options for hormone-refractory prostate cancer
    Miller, K.
    Boergermann, C.
    Thueroff, J.
    Albers, P.
    Wirth, M.
    [J]. UROLOGE, 2006, 45 (05): : 580 - +
  • [3] Management of hormone-refractory prostate cancer
    Dogliotti, L
    Mosca, A
    [J]. TUMORI, 2003, : S147 - S149
  • [4] Therapeutic options for hormone-refractory prostate cancer in 2007
    Hadaschik, Boris A.
    Gleave, Martin E.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2007, 25 (05) : 413 - 419
  • [5] Octreotide in the management of hormone-refractory prostate cancer
    Vainas, IG
    [J]. CHEMOTHERAPY, 2001, 47 : 109 - 126
  • [6] Revolutions in the management of hormone-refractory prostate cancer
    Abrahamsson, PA
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (03) : 1 - 2
  • [7] Therapeutic options in patients with hormone-refractory prostate cancer - Reply
    Figg, WD
    Middleman, MN
    Sartor, O
    [J]. AMERICAN JOURNAL OF MEDICINE, 1996, 100 (02): : 243 - 244
  • [8] Hormone-Refractory prostate cancer
    Rini B.I.
    Small E.J.
    [J]. Current Treatment Options in Oncology, 2002, 3 (5) : 437 - 446
  • [9] Update in the management of patients with hormone-refractory prostate cancer
    Moore, CN
    George, DJ
    [J]. CURRENT OPINION IN UROLOGY, 2005, 15 (03) : 157 - 162
  • [10] The role of urologists in the management of hormone-refractory prostate cancer
    Pummer, K
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2002, 1 (02) : 24 - 28